In PCa, mutational analysis of ETV6 in prostate carcinoma cell lines, xenografts, and metastatic foci revealed that an inactive protein might be produced that acts as a tumor-suppressor gene [159]. This evidence concerns the gene ETV6 and prostate carcinoma.